Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Kindred Biosciences Inc.

Kindred Biosciences Inc. (KIN)

Market is closed
News
  • Displaying 10
Is Kindred Biosciences (KIN) A Good Stock To Buy Now?

Is Kindred Biosciences (KIN) A Good Stock To Buy Now?

Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in...

Keep Reading →

December 11th, 2020 - Hedge Funds News

Hedge Funds Cautiously Watching Kindred Biosciences Inc (KIN)

Hedge Funds Cautiously Watching Kindred Biosciences Inc (KIN)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Keep Reading →

June 14th, 2020 - Hedge Funds News

Is Kindred Biosciences Inc (KIN) A Good Stock To Buy?

Is Kindred Biosciences Inc (KIN) A Good Stock To Buy?

Before we spend days researching a stock idea we like to take a look at how hedge funds and billionaire investors recently traded that stock.

Keep Reading →

December 23rd, 2019 - Hedge Funds News

Here's What Hedge Funds Think About Kindred Biosciences Inc (KIN)

Here's What Hedge Funds Think About Kindred Biosciences Inc (KIN)

Like everyone else, elite investors make mistakes. Some of their top consensus picks, such as Amazon, Facebook and Alibaba, have not done well in Q4 due to various reasons.

Keep Reading →

June 28th, 2019 - Hedge Funds News

13G Filing: Ariel Investments and Kindred Biosciences Inc. (KIN)

13G Filing: Ariel Investments and Kindred Biosciences Inc. (KIN)

You can access the original SEC filing by clicking here.

Keep Reading →

July 10th, 2017 - Hedge Funds

Should You Buy Kindred Biosciences Inc (KIN)?

Should You Buy Kindred Biosciences Inc (KIN)?

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.

Keep Reading →

December 16th, 2016 - Hedge Funds News

Kindred Biosciences, Inc. (KIN): Hedge Funds and Value Investors Are Crazy About It

Kindred Biosciences, Inc. (KIN): Hedge Funds and Value Investors Are Crazy About It

Kindred Biosciences Inc (NASDAQ:KIN) is a tiny stock, yet managed to attract high profile hedge funds and value investors.

Keep Reading →

April 8th, 2016 - Hedge Funds News

Is Kindred Biosciences Inc (KIN) Going to Burn These Hedge Funds?

Is Kindred Biosciences Inc (KIN) Going to Burn These Hedge Funds?

Many investors, including Carl Icahn or Stan Druckenmiller, have been saying for a while now that the current market is overvalued due to a low interest rate environment that leads to companies swapping...

Keep Reading →

December 2nd, 2015 - Hedge Funds News

Billionaire Seth Klarman's Top 3 Micro-Cap Stock Picks ~ Bellatrix Exploration Ltd (BXE), Kindred Biosciences Inc (KIN) and Alliance One International, Inc. (AOI)

Billionaire Seth Klarman's Top 3 Micro-Cap Stock Picks ~ Bellatrix Exploration Ltd (BXE), Kindred Biosciences Inc (KIN) and Alliance One International, Inc. (AOI)

The world’s 11th largest hedge fund, Seth Klarman’s Baupost Group, recently filed its 13F with the Securities and Exchange Commission for the end of the first quarter. Klarman founded Baupost Group...

Keep Reading →

May 25th, 2015 - Hedge Funds News

Seth Klarman's Baupost Group Initiates Stake in Kindred Biosciences Inc (KIN); Trims Holding in Enzon Pharmaceuticals Inc (ENZN)

Seth Klarman's Baupost Group Initiates Stake in Kindred Biosciences Inc (KIN); Trims Holding in Enzon Pharmaceuticals Inc (ENZN)

In two filings with the Securities and Exchange Commission, Baupost Group, a hedge fund managed by Seth Klarman, disclosed reducing its position in Enzon Pharmaceuticals Inc (NASDAQ:ENZN) and adding...

Keep Reading →

January 9th, 2014 - Hedge Funds News

Insider Monkey Quarterly Strategy
+334.6% Insider Monkey Quarterly Strategy
+149.4% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)